S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes ; volume:2 ; number:2 ; day:12 ; month:3 ; year:2014 ; pages:1 ; date:3.2014
Journal for ImmunoTherapy of Cancer ; 2, Heft 2 (12.3.2014), 1, 3.2014
- Urheber
-
Svane, I.
- Beteiligte Personen und Organisationen
-
Andersen, R.
Donia, M.
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-2-S2-I14
- URN
-
urn:nbn:de:1111-2016072711398
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Svane, I.
- Andersen, R.
- Donia, M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
S47. Tumour infiltrating lymphocytes - a predictive marker?
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer
Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy
S47. Tumour infiltrating lymphocytes - a predictive marker?
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer
Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy
S47. Tumour infiltrating lymphocytes - a predictive marker?
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer